Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene

Movement Disorders

Volumn 19, Issue 12, 2004, Pages 1450-1452

  Capecci, Marianna ^a   Passamonti, Luca ^a   Annesi, Ferdinanda ^b   Annesi, Grazia ^b   Bellesi, Michele ^a   Cirò Candiano, Innocenza Claudia ^b   Ricciuti, Riccardo ^a   Iacoangeli, Maurizio ^a   Scerrati, Massimo ^a   Zappia, Mario ^b,c   Tarantino, Patrizia ^b   De Marco, Elvira Valeria ^b   Civitelli, Donatella ^b   Carrideo, Sara ^b   Provinciali, Leonardo ^a   Ceravolo, Maria Gabriella ^a   Quattrone, Aldo ^b,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Deep brain subthalamic nucleus stimulation; Parkin gene; Parkinsonism

Indexed keywords

ALPRAZOLAM; CABERGOLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MIRTAZAPINE; PARKIN; QUETIAPINE;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG RESPONSE; DYSKINESIA; EXON; FUNCTIONAL ASSESSMENT; GENE DELETION; GENETIC DISORDER; GENETIC LINKAGE; HALLUCINATION; HOMOZYGOSITY; HUMAN; MALE; NEUROMODULATION; PARKINSONISM; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; SURGICAL APPROACH; TREATMENT OUTCOME;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DISABILITY EVALUATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; EXONS; FEMALE; GENE DELETION; GENOMIC IMPRINTING; HOMOZYGOTE; HUMANS; LEVODOPA; MALE; PARKINSONIAN DISORDERS; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS; UBIQUITIN-PROTEIN LIGASES;

EID: 19944428198     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20250     Document Type: Article

References (13)

1. Romito LM, Scerrati M, Contarino MF, Bentivoglio AR, Tonali P, Albanese A. Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology 2002;58:1546-1550.
2. Lagrange E, Krack P, Moro E, et al. Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD. Neurology 2002;59:1976-1978.
3. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
4. Pinter MM, Alesch F, Murg M, Seiwald M, Helscher RJ, Binder H. Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic Parkinson's disease: one year follow-up. J Neural Transm 1999;106:693-709.
5. Charles PD, Van Blercom, N, Krack P, et al. Predictors of effective bilateral subthalamic, nucleus stimulation for PD. Neurology 2002;59:932-934.
6. Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAP-SIT-PD). Mov Disord 1999;14:572-584.
7. Liu X, Rowe J, Nandi D, Hayward G, Stein J, Aziz T. Localization of the subthalamic nucleus using Radionics Image Fusion and Steroplan combined with field potential recording. A technical note. Stereotact Funct Neurosurg 2001;76:63-73.
8. Limousin P, Pollak P, Benazzouz A, et al. Bilateral subthalamic nucleus stimulation for severe Parkinson's disease. Mov Disord 1995;10:672-674.
9. Hattori N, Kitada T, Matsumine H, et al. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann Neurol 1998;44:935-941.
10. Bejjani BP, Damier P, Arnulf I, et al. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;340:1476-1480.
11. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002;125:575-583.
12. Leenders KL. Parkinson's disease and PET tracer studies. J Neural Transm Suppl 1988;27:219-225.
13. Yamamura Y, Hattori N, Matsumine H, et al. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000;22(Suppl. 1):87-91.